Format
Sort by

Send to

Choose Destination

Links from Books

Items: 19

1.

Power to the people.

Moynihan R.

BMJ. 2011 Apr 6;342:d2002. doi: 10.1136/bmj.d2002. No abstract available.

PMID:
21471161
2.

A systematic examination of the citation of prior research in reports of randomized, controlled trials.

Robinson KA, Goodman SN.

Ann Intern Med. 2011 Jan 4;154(1):50-5. doi: 10.7326/0003-4819-154-1-201101040-00007.

PMID:
21200038
3.

Commentary: practicalities of seeking consent and gaining understanding.

Gill R.

BMJ. 2010 Aug 24;341:c4000. doi: 10.1136/bmj.c4000. No abstract available.

PMID:
20736270
4.

Putting research into context--revisited.

Clark S, Horton R.

Lancet. 2010 Jul 3;376(9734):10-1. doi: 10.1016/S0140-6736(10)61001-X. No abstract available.

PMID:
20609979
5.

Reprint--preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.

Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group..

Phys Ther. 2009 Sep;89(9):873-80. No abstract available.

6.

Numbers needed to decide.

Woloshin S, Schwartz LM.

J Natl Cancer Inst. 2009 Sep 2;101(17):1163-5. doi: 10.1093/jnci/djp263. No abstract available.

7.

Deconstructing media coverage of trastuzumab (Herceptin): an analysis of national newspaper coverage.

Wilson PM, Booth AM, Eastwood A, Watt IS.

J R Soc Med. 2008 Mar;101(3):125-32. doi: 10.1258/jrsm.2007.070115.

8.
9.

"Breakthrough" drugs and growth in expenditure on prescription drugs in Canada.

Morgan SG, Bassett KL, Wright JM, Evans RG, Barer ML, Caetano PA, Black CD.

BMJ. 2005 Oct 8;331(7520):815-6. No abstract available.

10.

More nearly certain.

Evans I.

J R Soc Med. 2005 May;98(5):195-6. No abstract available.

11.

Confusion over benefits of hormone replacement therapy.

Huntingford CA.

Lancet. 2004 Jan 24;363(9405):332. No abstract available.

PMID:
14751720
12.

HARLOT plc: an amalgamation of the world's two oldest professions.

Sackett DL, Oxman AD; HARLOT plc..

BMJ. 2003 Dec 20;327(7429):1442-5. No abstract available.

13.

Screening for neuroblastoma in children.

Morris JK.

J Med Screen. 2002;9(2):56. No abstract available.

PMID:
12133921
15.

Business thrives on unproven care, leaving science behind: a special report.

Kolata G, Eichenwald K.

N Y Times Web. 1999 Oct 3:A1, A40-41. No abstract available.

PMID:
11647705
16.

Impure science: AIDS, activism, and the politics of knowledge.

Epstein S.

Med Soc (Berkeley). 1996:1-466. No abstract available.

PMID:
11619509
17.

Giving medicine a fair trial. Trials should not second guess what patients want.

Ashcroft R.

BMJ. 2000 Jun 24;320(7251):1686. No abstract available.

18.

Ethical issues. How can we distinguish clinical research from innovative therapy?

Lantos J.

Am J Pediatr Hematol Oncol. 1994 Feb;16(1):72-5.

PMID:
8311175
19.

Validation of screening procedures.

Cochrane AL, Holland WW.

Br Med Bull. 1971 Jan;27(1):3-8. Review. No abstract available.

PMID:
5100948
Items per page

Supplemental Content

Support Center